Can’t believe #ECTRIMS was 2 months ago! An honor to share the stage with greats in our field 😊
The 1st @ECTRIMS Patient Community Day report is now available: https://t.co/rcXAwLGQGb
Reuniting with this “French connection” in Paris next week for TSF France’s Patient Day 🇫🇷
The ECTRIMS-MEDEN Fellowship is aimed at fostering collaboration and research on #NMOSD & #MOGAD across Europe. Engage with leading experts & be part of a multi-centre effort.
📅 Apply by 1 Dec 2024.
Learn more: https://t.co/rE0JkC7Cen
#MEDEN#Fellowship
The ECTRIMS 2024 Patient Community Day brought together people living with #MS, clinicians, & researchers. In Part 1 of our new podcast, Elisabeth Kasilingam of @eumsplatform talks w/ @MSTranslate's Brett Drummond on how the event can empower patients.🎧➡️ https://t.co/OJq9zsEAaH
As @SelmaBlair’s acting career flourished in the 2000s, what fans didn’t see was that the actor was masking her symptoms on-screen and self-medicating through the pain. https://t.co/bVpHGAce76
ICCA is excited to share with you - ICCA Partnering for Success – providing regional insights into the global association meetings industry.
A must-read; whether you want to explore new destinations for your next association event.
Read more👉https://t.co/d6ic7A9bOT
In this issue of ECTRIMS Insights, we consider how the diagnosis of MS has progressed and the challenges that physicians continue to face, particularly in the differential diagnoses of different subtypes of #MS. Learn more ➡️ https://t.co/W5H6OR0uDa
“For young resesarchers it’s very motivating to come to ECTRIMS. This is the occasion for them to show their work, to obtain visibility, & to discuss”
Bruno Stankoff, ECTRIMS Vice President
Make your mark at #MSMilan2023. Submit your abstract today👇
https://t.co/ZTrkLYc2Yc
More pictures & wrap-up videos to follow, but in the meantime be sure to check out our #ECTRIMS2022 highlights. With over 8,700 people in attendance at this year's congress it was certainly easy to catch the vibe!
Discover the photographic highlights ▶️ https://t.co/yc6BIho5uf
🎙️ "I began this field more than 20 yrs ago at a time when I had 5 patients total with #MS in childhood. I didn’t have a lot of knowledge about MS in children because the entire literature took me less than a day to read: Brenda Banwell @ChildrensPhila
➡️ https://t.co/4DAq5LBOCH
The #ECTRIMS2022 mobile app is ready! Download, schedule your personal planner, and enjoy everything the world's largest international MS research congress has to offer:
Apple link: https://t.co/SS7kkPVEea
📣 BREAKING NEWS: #ECTRIMS2022 has been accredited with 18 European #CMEcredits by the European Accreditation Council for Continuing Medical Education! Register now for three exciting days in the latest updates in #MS research, treatment and care: https://t.co/0ZJKVKGHTU
#ECTRIMS2022 | Meet the speakers: @Mennoke from @amsterdamumc will be speaking on “The network collapse & clinical progression”
📅 Wed 26 Oct 14:30–16:00 CEST
Scientific Session 2: A network disease ➡️https://t.co/5nmGjSuxkd
View the full programme ➡️ https://t.co/rYgbXP83Hr
#ECTRIMS2022 | Hot Topic 3 is about the latest research on novel body fluid biomarkers and steps towards clinical implementation
📅 Wed, 26 Oct, 10:00–11:00 CEST
➡️https://t.co/35K7TFWE14
View the full Scientific Programme ➡️ https://t.co/rYgbXP83Hr
#MS is a disease that often occurs in women of childbearing age. Join us at #ECTRIMS2022 on 26-28 Oct in Amsterdam to hear about and discuss the latest research on treatment options. See the fully searchable programme for more ➡️ https://t.co/VqaDbppVY1
"In my experience, Congrex Switzerland is a reliable, accessible and responsive partner for the management of our association." - Prof. David Miler @ECTRIMS
Making decisions based on reliable and organised data makes your association more likely to succeed and grow.
Goals should be based on data such as:
➡️ Competitor landscape
➡️ Performance history
➡️ Membership retention
https://t.co/Z5QfHHjLuv
"Associations today face a world of constant change where it is increasingly difficult to achieve their objectives while maintaining a long-term vision."
Continue reading https://t.co/3sGe5ByOqV
Participants at #ECTRIMS2022 can engage with the latest research and developments on the use of #MRI in #MS diagnosis, prognosis and safety monitoring. Search our congress programme to find out more ➡️ https://t.co/VqaDbp8l6t